Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342728 · ClinicalTrials.gov registry record · NA
Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 214
- Enrollment target
NCT04342728 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 214 participants.
The verdict
NCT04342728, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the impact of ascorbic acid (vitamin c) and zinc gluconate in reducing duration of symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19). Patients above the age of 18 who present to the Cleveland Clinic outpatient testing and receive a positive test for COVID-19 will be invited to participate.
Interventions
- OTHER Standard of Care
- DIETARY_SUPPLEMENT Ascorbic Acid
- DIETARY_SUPPLEMENT Zinc Gluconate
- DIETARY_SUPPLEMENT Ascorbic Acid and Zinc Gluconate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2020-04-08 |
| Est. Completion | 2021-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04342728
The ClinicalTrials.gov registry entry for NCT04342728 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Standard of Care is the first listed.
NCT04342728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04342728 about?
NCT04342728 is a clinical study titled "Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation". The purpose of this study is to examine the impact of ascorbic acid (vitamin c) and zinc gluconate in reducing duration of symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19). Patients above the age of 18 who present to the Cleveland Clinic outpatient testing and receive a positi...
What is the current status of trial NCT04342728?
This trial is currently completed. It is a NA study. The enrollment target is 214 participants. The study started on 2020-04-08. Estimated completion is 2021-02-11.
What interventions are being tested in trial NCT04342728?
The interventions under investigation include: Standard of Care (OTHER), Ascorbic Acid (DIETARY_SUPPLEMENT), Zinc Gluconate (DIETARY_SUPPLEMENT), Ascorbic Acid and Zinc Gluconate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04342728?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.